LAEKNA-B (02105): Xie Ling and Zhou Jian appointed as members of the Nomination and Corporate Governance Committee.
Kailai Pharmaceuticals-B (02105) announced that as of December 12, 2025, Ms. Xie Ling, an Executive Director, and Mr. Zhou Jian, an Independent Non-executive Director, have been appointed as members of the company's Nomination and Corporate Governance Committee.
LAEKNA-B (02105) announced that as of December 12, 2025, Ms. Xie Ling, an executive director, and Mr. Zhou Jian, an independent non-executive director, have been appointed as members of the company's Nomination and Corporate Governance Committee.
Related Articles
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
